Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2015 1
2017 1
2020 2
2021 1
2022 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for anti ar[au]
Your search for Manti AR[au] retrieved no results
Molecular docking analysis of Adhatoda Vasica withThromboxane A2 receptor (TXA2R) (6IIU) and Antiviral molecules for possible dengue complications.
Thangaraju P, N G, Ar V, Gurunthalingam MP, Ty SS, Venkatesan S, Thangaraju E. Thangaraju P, et al. Among authors: ar v. Infect Disord Drug Targets. 2022 Jul 18. doi: 10.2174/1871526522666220718101544. Online ahead of print. Infect Disord Drug Targets. 2022. PMID: 35850647
Methods Docking studies are proved to be an essential tool that facilitates the structural diversity of natural products to be harnessed in an organized manner. In the present study, vasicine containing natural anti-dengue potential was subjected to docking studies using S …
Methods Docking studies are proved to be an essential tool that facilitates the structural diversity of natural products to be harnessed in …
Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic country.
Murt A, Elverdi T, Eskazan AE, Salihoglu A, Ar MC, Ongoren S, Baslar Z, Soysal T. Murt A, et al. Among authors: ar mc. Ann Hematol. 2020 Nov;99(11):2671-2677. doi: 10.1007/s00277-020-04206-z. Epub 2020 Jul 31. Ann Hematol. 2020. PMID: 32737632 Clinical Trial.
Fifteen patients were hepatitis B surface antigen (HBsAg)-positive patients (3 allogeneic and 12 autologous) while 51 of them were anti-hepatitis B core IgG (anti-HBc IgG)-positive patients (22 allogeneic and 29 autologous). ...Cumulative incidence increased to 41% …
Fifteen patients were hepatitis B surface antigen (HBsAg)-positive patients (3 allogeneic and 12 autologous) while 51 of them were anti …
Acute hepatitis B despite a previous high titer of anti-HBs.
Ozaras R, Ar C, Ongoren S, Mete B, Tabak F, Mert A, Ozturk R. Ozaras R, et al. Among authors: ar c. Hepatol Int. 2010 Apr 9;4(2):530-2. doi: 10.1007/s12072-010-9177-3. Hepatol Int. 2010. PMID: 20827412 Free PMC article.
CASE REPORT: We present here a case study of a patient with a previous high titer of anti-HBs who later developed HBV reactivation following intensive chemotherapy for leukemia. CONCLUSION: We conclude that in immunosuppressed patients with a history of HBV infection may c …
CASE REPORT: We present here a case study of a patient with a previous high titer of anti-HBs who later developed HBV reactivation fo …
Clinical Efficacy and Safety of Remdesivir among Hospitalised Adult Patients with RT PCR Confirmed COVID 19 Requiring ICU Care in Kalyana Karnataka.
Waddankeri S, Hesarur SS, Hiremath SS, A S, Ar S, Raikod BP, Kinagi S, Biradar S, Belli B, Melkundi S, Singh G. Waddankeri S, et al. Among authors: ar s. J Assoc Physicians India. 2021 Aug;69(8):11-12. J Assoc Physicians India. 2021. PMID: 34472806
BACKGROUND: Despite global efforts, COVID 19 pandemic is still posing a serious challenge with dearth of effective treatment options. Remdesivir has got FDA approval as the first COVID-19 anti-viral agent in adult and paediatric patients (aged 12 years and weighing at leas …
BACKGROUND: Despite global efforts, COVID 19 pandemic is still posing a serious challenge with dearth of effective treatment options. Remdes …
Clinical Outcomes Related to the Use of Bendamustine Therapy for Multiple Myeloma Patients Relapsed/Refractory to Immunomodulatory Drugs and Proteasome Inhibitors.
Yalnız FF, Akkoç N, Salihoğlu A, Ar MC, Öngören Ş, Eşkazan AE, Soysal T, Aydın Y. Yalnız FF, et al. Among authors: ar mc. Turk J Haematol. 2017 Aug 2;34(3):233-238. doi: 10.4274/tjh.2016.0397. Epub 2017 Mar 8. Turk J Haematol. 2017. PMID: 28270368 Free PMC article.
CONCLUSION: Bendamustine therapy was well tolerated but showed limited anti-myeloma activity in heavily pretreated patients who were refractory to IMiDs and PIs....
CONCLUSION: Bendamustine therapy was well tolerated but showed limited anti-myeloma activity in heavily pretreated patients who were …